New drug cocktail aims to shrink lung tumors in Late-Stage trial
NCT ID NCT07246863
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests a new drug called visugromab combined with nivolumab and chemotherapy (docetaxel) in people with advanced non-squamous lung cancer that has worsened after initial treatment. About 131 participants will receive different combinations to see if the new drug helps shrink tumors better than standard chemo alone. The goal is to find a more effective second-line treatment option.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Cantonal Hospital Saint Gallen, Clinic of Oncology and Hematology
RECRUITINGSankt Gallen, CH-9007, Switzerland
-
Clinica Polisano S.R.L
RECRUITINGSibiu, Sibiu County, 55023, Romania
-
Clinics Essen-Mitte
RECRUITINGEssen, North Rhine-Westphalia, 45136, Germany
-
Clínica Universidad de Navarra
RECRUITINGMadrid, Madrid, 28027, Spain
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
-
Evangelical Hospital Bethel, Clinic for Internal Medicine, Hematology/Oncology, Palliative Medicine Johannesstift
RECRUITINGBielefeld, North Rhine-Westphalia, 33611, Germany
-
Foundation Bethanien Moers
RECRUITINGMoers, North Rhine-Westphalia, 47441, Germany
-
Hospital Clinic of Barcelona
RECRUITINGBarcelona, Catalonia, 08036, Spain
-
Hospital Esslingen GmbH
RECRUITINGEsslingen am Neckar, Baden-Wurttemberg, 73730, Germany
-
Institute of Romagna for Cancer Research "Dino Amadori" - IRCCS IRST
RECRUITINGForlì, Emilia-Romagna, 47014, Italy
-
Local Health Unit of Romagna - Santa Maria delle Croci Hospital of Ravenna, Onco-Hematology Department
RECRUITINGRavenna, 48121, Italy
-
MED-Polonia, Sp. z o.o. (LLC)
RECRUITINGPoznan, Greater Poland Voivodeship, 60693, Poland
-
NYU Langone Hospital - Long Island
RECRUITINGMineola, New York, 11501, United States
-
NYU Longone Health
RECRUITINGNew York, New York, 10016, United States
-
National Cancer Institute Regina Elena, IRCCS
RECRUITINGRome, Lazio, 00144, Italy
-
Oncology Reference Center
RECRUITINGAviano, Friuli Venezia Giulia, 33081, Italy
-
Regional University Hospital of Malaga
RECRUITINGMálaga, Andalusia, 29010, Spain
-
SC Oncomed SRL
RECRUITINGTimișoara, Timiș County, 300239, Romania
-
START- Rioja
RECRUITINGLogroño, La Rioja, 26006, Spain
-
Sf. Nectarie Oncology Center
RECRUITINGCraiova, Dolj, 200542, Romania
-
Thorax Clinic Heidelberg
RECRUITINGHeidelberg, Baden-Wurttemberg, 69126, Germany
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University Clinic of Navarra - Pamplona
RECRUITINGPamplona, Navarre, 31008, Spain
-
University Hospital 12 de Octubre
RECRUITINGMadrid, Madrid, 28041, Spain
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
-
University Hospital Complex of Santiago (CHUS)
RECRUITINGSantiago de Compostela, Galicia, 15706, Spain
-
University Hospital HM Sanchinarro
RECRUITINGMadrid, Madrid, 28050, Spain
-
University Hospital Lucus Augusti (HULA)
RECRUITINGLugo, 27003, Spain
-
University Hospital Virgen del Rocio (HUVR)
RECRUITINGSeville, Andalusia, 41013, Spain
-
University Hospital Wuerzburg, Clinic and Polyclinic II for Gastroenterology, Hematology, Internal Oncology, Stem Cell Therapies, Hepatology, Infectiology, Psychosomatics and Rheumatology/ Clinical Immunology
RECRUITINGWürzburg, Bavaria, 97080, Germany
-
University Hospital of Girona Dr. Josep Trueta
RECRUITINGGirona, Girona, 17007, Spain
-
University Hospital of Jaen
RECRUITINGJaén, Andalusia, 23007, Spain
-
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center)
RECRUITINGBirmingham, Alabama, 35294-3300, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill combo outperform standard therapy for a Hard-to-Treat lung cancer?
- New MET inhibitor DO-2 enters human trials for Hard-to-Treat cancers
- New combo therapy shows promise for hard-to-treat childhood cancers
- New drug combo aims to boost bladder cancer remission before surgery
- Epigenetic and immune drugs join forces against tough tumors
- New pill takes on tough cancers: first human trial begins